Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma
- PMID: 24143196
- PMCID: PMC3797098
- DOI: 10.1371/journal.pone.0076967
Association of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinoma
Abstract
Increasing epidemiological evidence has indicated that inherited variations of mitochondrial DNA (mtDNA) copy number affect the genetic susceptibility of many malignancies in a tumour-specific manner and that DNA methylation also plays an important role in controlling gene expression during the differentiation and development of hepatocellular carcinoma (HCC). Our previous study demonstrated that HCC tissues showed a lower 5-hydroxymethylcytosine (5-hmC) content when compared to tumour-adjacent tissues, but the relationship among 5-hmC, 5-methylcytosine (5-mC) and mtDNA content in HCC patients is still unknown. This study aimed to clarify the correlation among mtDNA content, 5-mC and 5-hmC by quantitative real-time PCR and liquid chromatography tandem mass spectrometry analysis. We demonstrated that 5-hmC correlated with tumour size [odds ratio (OR) 0.847, 95% confidence interval (CI) 0.746-0.962, P = 0.011], and HCC patients with a tumour size ≥ 5.0 cm showed a lower 5-hmC content and higher levels of fasting plasma aspartate aminotransferase, the ratio of alanine aminotransferase to aspartate aminotransferase, γ-glutamyltransferase, alpha-fetoprotein than those with a tumour size <5 cm (all P<0.05). We further revealed that the mtDNA content of HCC tumour tissues was 225.97(105.42, 430.54) [median (25th Percentile, 75th Percentile)] and was negatively correlated with 5-mC content (P = 0.035), but not 5-hmC content, in genomic DNA from HCC tumour tissues.
Conflict of interest statement
Figures


Similar articles
-
Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.Cell Prolif. 2019 Jul;52(4):e12626. doi: 10.1111/cpr.12626. Epub 2019 Apr 29. Cell Prolif. 2019. PMID: 31033072 Free PMC article. Review.
-
Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.PLoS One. 2013 May 9;8(5):e62828. doi: 10.1371/journal.pone.0062828. Print 2013. PLoS One. 2013. PMID: 23671639 Free PMC article.
-
Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry.Clin Chem. 2013 May;59(5):824-32. doi: 10.1373/clinchem.2012.193938. Epub 2013 Jan 23. Clin Chem. 2013. PMID: 23344498 Free PMC article.
-
Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma.Int J Oncol. 2016 Aug;49(2):589-602. doi: 10.3892/ijo.2016.3535. Epub 2016 May 24. Int J Oncol. 2016. PMID: 27221337
-
Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma.World J Gastroenterol. 2013 Dec 21;19(47):8880-6. doi: 10.3748/wjg.v19.i47.8880. World J Gastroenterol. 2013. PMID: 24379611 Free PMC article. Review.
Cited by
-
Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.Cell Prolif. 2019 Jul;52(4):e12626. doi: 10.1111/cpr.12626. Epub 2019 Apr 29. Cell Prolif. 2019. PMID: 31033072 Free PMC article. Review.
-
Association of global DNA hypomethylation with clinicopathological variables in colonic tumors of Iraqi patients.Saudi J Gastroenterol. 2016 Mar-Apr;22(2):139-47. doi: 10.4103/1319-3767.178525. Saudi J Gastroenterol. 2016. PMID: 26997221 Free PMC article.
-
Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma.Med Oncol. 2024 Oct 27;41(12):302. doi: 10.1007/s12032-024-02538-8. Med Oncol. 2024. PMID: 39465473 Review.
References
-
- Mathews CK (2006) DNA precursor metabolism and genomic stability. FASEB J 20: 1300–1314. - PubMed
-
- Lee HC, Yin PH, Lin JC, Wu CC, Chen CY, et al. (2005) Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci 1042: 109–122. - PubMed
-
- Yu M, Shi Y, Wei X, Yang Y, Zang F, et al. (2009) Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells. Eur J Cancer Prev 18: 445–457. - PubMed
-
- Villa AM, Fusi P, Pastori V, Amicarelli G, Pozzi C, et al. (2012) Ethidium bromide as a marker of mtDNA replication in living cells. J Biomed Opt 17: 046001. - PubMed
-
- Navratil M, Poe BG, Arriaga EA (2007) Quantitation of DNA copy number in individual mitochondrial particles by capillary electrophoresis. Anal Chem 79: 7691–7699. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical